# Use of a Vertical Traction Device in the Management of an Open Abdomen: A Case Report

## TL;DR

This case report describes the successful use of a vertical traction device to manage a patient with severe pancreatitis and abdominal compartment syndrome.

## Contribution

The report highlights the novel use of Fasciotens® Abdomen in combination with Botox and NPWT for managing an open abdomen.

## Key findings

- FTA application reduced fascial distance by 8 cm within 48 hours.
- Definitive fascial closure was achieved within 10 days using FTA alongside Botox and NPWT.
- The case demonstrates the efficacy and safety of FTA in managing abdominal compartment syndrome.

## Abstract

A laparostomy procedure, a critical intervention frequently employed in both trauma and non-trauma patients, is a key component of damage control resuscitation. The use of a vertical traction device (VTD), specifically Fasciotens® Abdomen (FTA), is a relatively novel technology that prevents fascial retraction and facilitates primary fascial closure. This report describes the case of a male in his 20s with severe pancreatitis, complicated by multi-organ failure and abdominal compartment syndrome (ACS), necessitating decompressive laparotomy. FTA was applied alongside botulinum toxin (Botox) and negative pressure wound therapy (NPWT), achieving definitive closure within 10 days. Fascial distance was reduced by 8 cm within 48 hours of FTA application. This case highlights FTA’s efficacy and safety, supported by the Liverpool Hospital Trauma Acute Care Surgery (TACS) wound bundle.